The effectiveness of radioiodine therapy depends on the presence of active NIS on the plasma membrane of cells.15 Low levels of NIS gene expression are often observed in patients with thyroid cancer, resulting in reduced iodine accumulation. Here, SLC5A5 is linked to thyroid gland carcinoma.